ArticleInternational journal of general medicine2023

KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma.

Zhe Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.